Dr. Timothy S. Kristedja, MD

Dr. Kristedja practices at Santa Monica Surgicenter in Santa Monica, California.

Dr. Kristedja's NPI, 1881897494, was assigned on June 9, 2007. Dr. Kristedja graduated from University of Dublin Trinity College in 2006. Dr. Kristedja holds California license A108522.

Dr. Kristedja's primary practice is Santa Monica Surgicenter, at 2001 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5550.

Dr. Kristedja's primary practice is Santa Monica Surgicenter in Santa Monica, California. Dr. Kristedja is also affiliated with Providence Saint John's Health Center. The medical group on file is Saint John's Physician Partners. Dmand AI also links Dr. Kristedja to 1 more community health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kristedja practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kristedja's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kristedja is board certified in hematology by the American Board of Internal Medicine. Dr. Kristedja is licensed in California.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic embolism thrombosis, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Kristedja treats.

CMS data shows 37,785 Medicare services from Dr. Kristedja across 31 procedure codes in 2024, for 607 Medicare patients. Medicare paid $277,369 for them.

CMS counts 607 Medicare patients who saw Dr. Kristedja in 2024. The largest group is 75 to 84, with 235 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kristedja's median patient age at 70, with 61% women.

In 2024, Dr. Kristedja wrote 898 Medicare Part D claims for 150 patients. 66% of them were for generic drugs. CMS names the drug for 625 of them, across 25 drugs with 11 or more claims each, at $1,787,994 in total drug cost. In 2023, CMS named 483 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Kristedja for performance year 2024, reported as part of a group. Dr. Kristedja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kristedja as offering telehealth.

Dmand AI links 5 papers to Dr. Kristedja. The most frequent topics are Melanoma, Tamoxifen and Antibodies, Monoclonal, Humanized. Dr. Kristedja's most frequent co-authors are Steven J. O'Day, MD, Luke Philip Dreisbach, MD and Mohammed Mahmoud Milhem, MBBS.

CMS Open Payments shows 47 general payments to Dr. Kristedja from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Janssen Pharmaceuticals, Inc paid the most, $523.

Dr. Kristedja graduated from University of Dublin Trinity College in 2006.

Dr. Kristedja is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.